Anticholinergic Deprescription in Schizophrenia

PHASE4RecruitingINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

June 30, 2029

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG

Anticholinergic Deprescription

per routine clinical care, people in the active arm of the study will undergo deprescription of benztropine or trihexyphenidyl per routine clinical care.

DRUG

No Anticholinergic Deprescription

In this arm, no deprescription of benztropine or trihexyphenidyl will occur.

Trial Locations (1)

15213

RECRUITING

UPMC Western Psychiatric Hospital/University of Pittsburgh, Pittsburgh

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Deepak K. Sarpal, M.D.

OTHER